<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03455751</url>
  </required_header>
  <id_info>
    <org_study_id>17-1540</org_study_id>
    <nct_id>NCT03455751</nct_id>
  </id_info>
  <brief_title>Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery</brief_title>
  <acronym>PPaM</acronym>
  <official_title>Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objectives of this study are to evaluate the potential for preoperative
      pharmacogenomics (PGx) testing to positively influence postoperative opioid use through
      visual analog scale (VAS) guided administration of narcotic equivalent and lower pain scores
      as measured by OBAS in patients undergoing major abdominal surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2018</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative opioid use</measure>
    <time_frame>Post-op day 1</time_frame>
    <description>Post-operative opioid use through visual analog scale guided administration of narcotic equivalent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Benefit of Analgesia Score (OBAS)</measure>
    <time_frame>Post-op day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission rate</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional status</measure>
    <time_frame>4 weeks and 3 months</time_frame>
    <description>Assessed through Duke Activity Status Index (DASI)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">336</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Diverticular Disease</condition>
  <condition>Crohn Disease</condition>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm will receive no intervention and will follow standard of care for post-operative pain management.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PGx-guided</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The PGx-guided arm will received altered post-operative pain management based on the results of pharmacogenomic testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>PGx-guided post-operative pain management</intervention_name>
    <description>Post-operative pain management as indicated by pharmacogenomic testing results.</description>
    <arm_group_label>PGx-guided</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject capable of giving consent

          -  Age 18-80

          -  Scheduled for open colorectal resection at Cleveland Clinic main campus (with
             preoperative appointment scheduled at least five days before date of surgery)

        Exclusion Criteria:

          -  Patient does not speak English

          -  Patient with substance-use disorder (including alcohol)

          -  Patient diagnosed with major depression

          -  Patient currently taking opioids

          -  Previous long-term opioid use (&gt; 3 months)

          -  Previous opioid use with a dose of &gt;100 milligram morphine equivalent (MME)

          -  Patient has pain-related disorder (e.g. fibromyalgia, sympathetic dystrophy, etc.)

          -  Documented allergy to pain medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Liska, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Callie Merry, PhD</last_name>
    <phone>216-444-5987</phone>
    <email>merryc@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Callie Merry, PhD</last_name>
      <phone>216-444-5987</phone>
      <email>merryc@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2018</study_first_submitted>
  <study_first_submitted_qc>March 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 7, 2018</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>David Liska</investigator_full_name>
    <investigator_title>Associate Staff, Colorectal Surgery</investigator_title>
  </responsible_party>
  <keyword>Pain Management</keyword>
  <keyword>Pharmacogenomics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Diverticulum</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

